Custom service
Targeting Peptide Quality Testing and Purification
Purify and qc targeting peptides made elsewhere to a release-grade standard
Teams come to this service when they need to purify and QC targeting peptides made elsewhere to a release-grade standard. We typically start from RP-HPLC and ion-exchange purification, add binding-affinity confirmation where the application demands it, and close the loop with impurity profiling so the final purified material with full QC report behaves consistently across lots.
Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 1–3 weeks timeline holds in practice.
Rescuing crude material from failed internal syntheses
Independent QC before a critical experiment
Material so impure that re-synthesis is cheaper
Targets whose soluble ectodomain cannot be produced or sourced for binding assays
Binding affinity and specificity data are generated in-house for every campaign: IC50 or Kd against the intended target, plus counterscreens against the closest homologs. Release also includes purity, identity and, for conjugated variants, loading ratio.
Service Highlights
- RP-HPLC and ion-exchange purification as the default route, with binding-affinity confirmation held as a proven fallback
- Impurity profiling worked into the design where the application requires it
- Receptor-binding assays run against the intended target before any scale-up
- Analytical confirmation of every intermediate before the final release
- Specificity is measured against a negative-cell or negative-receptor panel, not asserted
- Purified material with full QC report delivered with a complete conjugation or synthesis certificate
How the work runs
Target analysis
We map the binding site, receptor biology and homolog panel that the Targeting Peptide Quality Testing and Purification campaign must respect.
Motif selection or discovery
A motif is selected from literature, or discovered by screening, and candidate sequences are ranked.
Synthesis & modification
Candidates are synthesized with RP-HPLC and ion-exchange purification applied to stabilize or direct the motif.
Binding & specificity testing
Affinity is measured on the target and counterscreens run on homologs and irrelevant cells.
Optimization round
Sequences are iterated — alanine scanning, truncation, D-substitution — until the specification is met.
Scale-up & release
The final variant is produced in quantity and Purified material with full QC report is released with the full data package.
Specifications & timeline
- Turnaround
- 1–3 weeks
- Typical scale
- 1 – 100 mg targeting peptide
- Chemistry options
- RP-HPLC and ion-exchange purification; binding-affinity confirmation; impurity profiling
- Deliverable
- Purified material with full QC report
- QC package
- HPLC purity, MS identity, binding assay report
- Shipping
- Ambient or blue ice as stability requires
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.